These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 35900718

  • 1. New data on efficacy of valacyclovir in secondary prevention of maternal-fetal transmission of cytomegalovirus.
    Egloff C, Sibiude J, Vauloup-Fellous C, Benachi A, Bouthry E, Biquard F, Hawkins-Villarreal A, Houhou-Fidouh N, Mandelbrot L, Vivanti AJ, Picone O.
    Ultrasound Obstet Gynecol; 2023 Jan; 61(1):59-66. PubMed ID: 35900718
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness and safety of prenatal valacyclovir for congenital cytomegalovirus infection: systematic review and meta-analysis.
    D'Antonio F, Marinceu D, Prasad S, Khalil A.
    Ultrasound Obstet Gynecol; 2023 Apr; 61(4):436-444. PubMed ID: 36484439
    [Abstract] [Full Text] [Related]

  • 3. Secondary prevention of congenital cytomegalovirus infection with valacyclovir following maternal primary infection in early pregnancy.
    Faure-Bardon V, Fourgeaud J, Stirnemann J, Leruez-Ville M, Ville Y.
    Ultrasound Obstet Gynecol; 2021 Oct; 58(4):576-581. PubMed ID: 33998084
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Outcome of pregnancies with recent primary cytomegalovirus infection in first trimester treated with hyperimmunoglobulin: observational study.
    Kagan KO, Enders M, Hoopmann M, Geipel A, Simonini C, Berg C, Gottschalk I, Faschingbauer F, Schneider MO, Ganzenmueller T, Hamprecht K.
    Ultrasound Obstet Gynecol; 2021 Apr; 57(4):560-567. PubMed ID: 33491819
    [Abstract] [Full Text] [Related]

  • 8. Fetal and maternal outcome after hyperimmunoglobulin administration for prevention of maternal-fetal transmission of cytomegalovirus during pregnancy: retrospective cohort analysis.
    Seidel V, Hackelöer M, Rancourt RC, Henrich W, Siedentopf JP.
    Arch Gynecol Obstet; 2020 Dec; 302(6):1353-1359. PubMed ID: 32754858
    [Abstract] [Full Text] [Related]

  • 9. Case report on early treatment with valaciclovir after maternal primary cytomegalovirus infection.
    Codaccioni C, Vauloup-Fellous C, Letamendia E, Saada J, Benachi A, Vivanti AJ.
    J Gynecol Obstet Hum Reprod; 2019 Apr; 48(4):287-289. PubMed ID: 30634004
    [Abstract] [Full Text] [Related]

  • 10. Prevention of maternal-fetal transmission of cytomegalovirus after primary maternal infection in the first trimester by biweekly hyperimmunoglobulin administration.
    Kagan KO, Enders M, Schampera MS, Baeumel E, Hoopmann M, Geipel A, Berg C, Goelz R, De Catte L, Wallwiener D, Brucker S, Adler SP, Jahn G, Hamprecht K.
    Ultrasound Obstet Gynecol; 2019 Mar; 53(3):383-389. PubMed ID: 29947159
    [Abstract] [Full Text] [Related]

  • 11. Prevention of Congenital Cytomegalovirus Infection: Review and Case Series of Valaciclovir versus Hyperimmune Globulin Therapy.
    Nigro G, Muselli M, On Behalf Of The Congenital Cytomegalic Disease Collaborating Group.
    Viruses; 2023 Jun 15; 15(6):. PubMed ID: 37376675
    [Abstract] [Full Text] [Related]

  • 12. First-trimester diagnosis of congenital cytomegalovirus infection after maternal primary infection in early pregnancy: feasibility study of viral genome amplification by PCR on chorionic villi obtained by CVS.
    Faure-Bardon V, Fourgeaud J, Guilleminot T, Magny JF, Salomon LJ, Bernard JP, Leruez-Ville M, Ville Y.
    Ultrasound Obstet Gynecol; 2021 Apr 15; 57(4):568-572. PubMed ID: 33533526
    [Abstract] [Full Text] [Related]

  • 13. Recurrent congenital cytomegalovirus infection in a sequential pregnancy with severe sequelae, and a possible association with prophylactic valacyclovir treatment: a case report.
    Brosh-Nissimov T, Benshalom-Tirosh N, Bucris E, Morad H, Zuckerman NS, Tepperberg Oikawa M.
    Int J Infect Dis; 2022 Dec 15; 125():93-95. PubMed ID: 36229004
    [Abstract] [Full Text] [Related]

  • 14. Describing the Impact of Maternal Hyperimmune Globulin and Valacyclovir on the Outcomes of Cytomegalovirus Infection in Pregnancy: A Systematic Review.
    Fitzpatrick A, Cooper C, Vasilunas N, Ritchie B.
    Clin Infect Dis; 2022 Oct 12; 75(8):1467-1480. PubMed ID: 35438780
    [Abstract] [Full Text] [Related]

  • 15. In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study.
    Leruez-Ville M, Ghout I, Bussières L, Stirnemann J, Magny JF, Couderc S, Salomon LJ, Guilleminot T, Aegerter P, Benoist G, Winer N, Picone O, Jacquemard F, Ville Y.
    Am J Obstet Gynecol; 2016 Oct 12; 215(4):462.e1-462.e10. PubMed ID: 27083761
    [Abstract] [Full Text] [Related]

  • 16. Prevention and treatment of fetal cytomegalovirus infection with cytomegalovirus hyperimmune globulin: a multicenter study in Madrid.
    Blázquez-Gamero D, Galindo Izquierdo A, Del Rosal T, Baquero-Artigao F, Izquierdo Méndez N, Soriano-Ramos M, Rojo Conejo P, González-Tomé MI, García-Burguillo A, Pérez Pérez N, Sánchez V, Ramos-Amador JT, De la Calle M.
    J Matern Fetal Neonatal Med; 2019 Feb 12; 32(4):617-625. PubMed ID: 28978246
    [Abstract] [Full Text] [Related]

  • 17. Revisiting short- and long-term outcome after fetal first-trimester primary cytomegalovirus infection in relation to prenatal imaging findings.
    Lipitz S, Elkan Miller T, Yinon Y, Weissbach T, De-Castro H, Hoffman C, Katorza E, Weisz B.
    Ultrasound Obstet Gynecol; 2020 Oct 12; 56(4):572-578. PubMed ID: 31858642
    [Abstract] [Full Text] [Related]

  • 18. Management of cytomegalovirus infection in pregnancy: is it time for valacyclovir?
    Zammarchi L, Lazzarotto T, Andreoni M, Campolmi I, Pasquini L, Di Tommaso M, Simonazzi G, Tomasoni LR, Castelli F, Galli L, Borchi B, Clerici P, Bartoloni A, Tavio M, Trotta M.
    Clin Microbiol Infect; 2020 Sep 12; 26(9):1151-1154. PubMed ID: 32289479
    [Abstract] [Full Text] [Related]

  • 19. Asymptomatic CMV infection at birth following maternal primary infection despite valacyclovir treatment and a subsequent negative amniocentesis. Case report.
    Toti MS, Zammarchi L, Pasquini L, Campolmi I, Modi G, Borchi B, Bartoloni A, Trotta M, Galli L, Bernardini R.
    Eur J Obstet Gynecol Reprod Biol; 2023 Dec 12; 291():128-130. PubMed ID: 37871349
    [Abstract] [Full Text] [Related]

  • 20. Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial.
    Shahar-Nissan K, Pardo J, Peled O, Krause I, Bilavsky E, Wiznitzer A, Hadar E, Amir J.
    Lancet; 2020 Sep 12; 396(10253):779-785. PubMed ID: 32919517
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.